
Even patients with a 5-year risk for major vascular events <10% may benefit from primary prevention using statin therapy, according to the results of a large meta-analysis. This study may hold particular significance for patients in India, where genetic susceptibility results in a higher rate of vascular events, and where…
Read more »
Statin benefits in primary prevention outweigh risk of diabetes
The benefit of preventing vascular events outweighs the increased risk of new-onset diabetes in patients without cardiovascular disease but with an elevated level of high-sensitivity C-reactive protein (hs-CRP), researchers have found. India is the country with the greatest number of diabetes patients in the world, according to the International Diabetes…
Read more »